Article
Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into…
bioRxiv: the preprint server for biology · 2022 · Payton A.-B. Weidenbacher, author Eric Waltari, author Izumi de los Rios Kobara, author Benjamin N. Bell, author John E. Pak, author Peter S. Kim, author
Key facts
| Title | Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade |
|---|---|
| First author | Payton A.-B. Weidenbacher, author Eric Waltari, author Izumi de los Rios Kobara, author Benjamin N. Bell, author John E. Pak, author Peter S. Kim, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Feb 15, 2022 |
| DOI | 10.1101/2022.01.24.477625 |
| Devices mentioned | 091298, K202641, K231013, K760686, K973350, K990827 |
| Product codes mentioned | GEH, JLX, KQP, QBD, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1